rotation.to
Following this device: dark.
Free account
rotation.to
Appearance
Following this device: dark.
Drag a card by its title · ⚙ to size, swap or remove

The company

Dogwood Therapeutics, Inc.

DWTX · Nasdaq

Health CareBiotechnologyNot moving yet

DWTX stood above a rising 150-day average in 7 of the last 52 weekly readings, and has been out of that trend for the last 43 weeks. It is 31.0% below that average now. Biotechnology: 15% of its 561 stocks in an uptrend (−17 points in four weeks); Health Care: 25% (−11 points in four weeks).

Statistics

Rotation
Not moving yet
Weeks in an uptrend
out for 43
Industry in uptrend
15% -17 in 4 wk
Insider buys, 12 months
$0
Insider sales, 12 months
$0
Officials’ trades on record
0
Institutions holding
16 (+3)

In the rotation

Each square a week: lit when it closed above a rising 150-day average. 7 of 52 weeks.

17 Apr – 16 Oct
16%28%39%Apr 26Jun 26Jul 26Sep 26Oct 26

Biotechnology: Few of its stocks are in an uptrend and the share has fallen sharply over four weeks. Health Care: A minority of its stocks are in an uptrend and the share has fallen sharply over four weeks.

Money in and out

1 Nov 2024 – 1 Oct 2026
−$1$0$1Nov 24May 25Nov 25Apr 26Oct 26

Open-market buys above the line and sales below, in dollars.

Congress and officials

No member of Congress or official has disclosed a trade in it.

Insiders

Buy orders, 12 months0
Sale orders, 12 months0
Buyers · sellers0 · 0

No open-market buy or sale by its insiders on record.

Lines filed since 2 January 2026, newest first; every insider’s older lines are on their own page.

Institutions

Holders16+3 on the quarter
New · exited6 · 3
Reported value$6.2M

Quarter to 30 Jun 2026, against 31 Mar 2026; newest filing 31 Aug 2026.

ManagerSharesChange
ARMISTICE CAPITAL, LLCreduced · filed 14 Aug 20263,132,486$5.0M-147,514−4.5%
MILLENNIUM MANAGEMENT LLCnew · filed 14 Aug 2026341,814$550K+341,814
VANGUARD CAPITAL MANAGEMENT LLCunchanged · filed 13 Aug 2026132,154$213K00.0%
GEODE CAPITAL MANAGEMENT, LLCadded · filed 12 Aug 202688,298$142K+8,864+11.2%
VANGUARD FIDUCIARY TRUST COunchanged · filed 13 Aug 202662,736$101K00.0%
BlackRock, Inc.added · filed 7 Aug 202628,546$46K+28,516+95053.3%
NORTHERN TRUST CORPunchanged · filed 13 Aug 202623,779$38K00.0%
CITADEL ADVISORS LLCnew · filed 14 Aug 202611,742$19K+11,742
Tower Research Capital LLC (TRC)reduced · filed 11 Aug 20263,093$4,980-4,974−61.7%
MORGAN STANLEYnew · filed 13 Aug 20262,222$3,577+2,222
31 Dec 2024 – 30 Jun 2026
101316Dec 24Jun 25Sep 25Mar 26Jun 26

News

No headline names it lately.

Everyone who traded it

Abel De La Rosa Company insiderDirector · last 16 Jun 20261 · 0
David R. Keefer Company insiderDirector · last 16 Jun 20261 · 0
John C. Thomas Company insiderDirector · last 16 Jun 20261 · 0
Richard James Whitley Company insiderDirector · last 16 Jun 20263 · 1
Angela Walsh Company insiderChief Financial Officer · last 5 Mar 20262 · 0
Gregory Scott Duncan Company insiderCHIEF EXECUTIVE OFFICER · last 5 Mar 20266 · 0
Ralph Grosswald Company insiderSVP OF OPERATIONS · last 5 Mar 20260 · 0
Roger Michael Gendreau Company insiderCHIEF MEDICAL OFFICER · last 5 Mar 20260 · 0
Conjoint Inc. Company insiderDirector, 10% owner, Other · last 21 Nov 20250 · 0
Ck Life Sciences Intl (Holdings) Inc Company insiderDirector, 10% owner, Other · last 12 Mar 20250 · 0
Richard Alan Burch Company insiderDirector · last 26 Feb 20240 · 0
William Pridgen Company insiderDirector · last 26 Feb 202411 · 0

Same industry

MRNA ModernaLeading+147%
ENTX Entera BioLeading+37%
XNCR XencorLeading+30%

Distance from each stock’s own 150-day average.

Government contracts

No federal award is tied to it.

From its SEC filings

Return on capital employedFY 2025 · to 31 Dec 2025-32.1%
Share count trendFY 2025 · to 10 Mar 202612.3%
Cash and equivalentsFY 2025 · to 31 Dec 2025$6.5M

Analyst forecasts

No analyst forecasts yet.